Congenital Sucrase-isomaltase Deficiency
📧 Sign up to get email alerts when something new happens for Congenital Sucrase-isomaltase Deficiency.
Sign up freeTop drugs studied for this disease
-
FDA label_change · 2024-07-24FDA Approved: SUCRAID — Supplemental Application (QOL Medical, LLC)
FDA approved a supplemental application for SUCRAID (sacrosidase) from QOL Medical, LLC, resulting in changes to the product labeling.